Recently, van der Vaart et al.25 showed that the treatment of adult tissue-derived organoids with Graves’ disease patients' sera lead to increased proliferation and hormone secretion after thyrotropin receptor (TSHR)-antibody stimulation, showing the applicability of the system to model thyroid diseases25. This evidence concerns the gene TSHR and Graves disease.